Bellon Christine's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Feb 19, 2025
- Accession no.
- 0000950170-25-023166
- Filed
- Feb 19, 2025
- Trade date
- Feb 14, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $340.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bellon ChristineCIK 0001963878 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Common Stock | MOption exerciseAcquired | +9,492 | $7.22 | +$68,532.24 | 112,460 | Direct | |
| Feb 14, 2025 | Common Stock | MOption exerciseAcquired | +508 | $7.22 | +$3,667.76 | 112,968 | Direct | |
| Feb 14, 2025 | Common Stock | SSaleDisposed | −10,000 | $34.00 | −$340,000 | 102,968 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Common Stock | MOption exerciseDisposed | −9,492 | $0.00 | $0 | 0 | Direct | |
| Feb 14, 2025 | Common Stock | MOption exerciseDisposed | −508 | $0.00 | $0 | 10,410 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.